
Dry Eye




May 08, 2025
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap
Ophthalmology Management

Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.




Advertisement
Recommendations
Advertisement